The impact of central obesity as a prerequisite for the diagnosis of metabolic syndrome

Obesity

Volumn 15, Issue 1, 2007, Pages 262-269

  Khoo, Chin Meng ^a   Liew, Choon Fong ^a   Chew, Suok Kai ^b   Tai, E Shyong ^c  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b MINISTRY OF HEALTH   (Singapore)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Asian; Cardiovascular risk; Central obesity; Insulin resistance; Metabolic syndrome

Indexed keywords

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CHI SQUARE DISTRIBUTION; CLASSIFICATION; CROSS-SECTIONAL STUDY; ETHNOLOGY; FEMALE; HEALTH SURVEY; HUMAN; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; OBESITY; PHENOTYPE; PREDICTION AND FORECASTING; PREVALENCE; RISK FACTOR; SINGAPORE; WAIST HIP RATIO;

ADULT; AGED; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS; SINGAPORE; WAIST-HIP RATIO;

EID: 33846869727     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2007.559     Document Type: Article

References (27)

1. Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes. 1988;37:1595-607.
2. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998; 15:539-53.
3. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation: European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999; 16:442-3.
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
5. Einhorn D, Reaven GM, Cobin RH, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003;9:237-52.
6. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome: a new worldwide definition. Lancet. 2005;366:1059-62.
7. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735-52.
8. Palaniappan L, Carnethon MR, Wang Y, et al. Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 2004;27:788-93.
9. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab. 2004;89:2569-75.
10. St-Pierre AC, Cantin B, Mauriege P, et al. Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. CMAJ. 2005;172:1301-5.
11. Cutter J, Tan BY, Chew SK. Levels of cardiovascular disease risk factors in Singapore following a national intervention programme. Bull World Health Organ. 2001;79:908-15.
12. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-47.
13. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996;3:213-9.
14. Despres JP, Lemieux I, Dagenais GR, Cantin B, Lamarche B. HDL-cholesterol as a marker of coronary heart disease risk: the Quebec cardiovascular study. Atherosclerosis. 2000; 153:263-72.
15. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet. 1992;340:925-9.
16. Haffner SM, Miettinen H, Gaskill SP, Stern MP. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes. 1995;44:1386-91.
17. Despres JP, Lamarche B, Mauriege P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996;334:952-7.
18. Howard G, O'Leary DH, Zaccaro D, et al. Insulin sensitivity and atherosclerosis: the Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation. 1996;93:1809-17.
19. Wang JJ, Qiao Q, Miettinen ME, Lappalainen J, Hu G, Tuomilehto J. The metabolic syndrome defined by factor analysis and incident type 2 diabetes in a Chinese population with high postprandial glucose. Diabetes Care. 2004;27:2429-37.
20. Keil U, Chambless L, Filipiak B, Hartel U. Alcohol and blood pressure and its interaction with smoking and other behavioural variables: results from the MONICA Augsburg Survey 1984-1985. J Hypertens. 1991;9:491-8.
21. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM. Insulin resistance and cigarette smoking. Lancet. 1992;339:1128-30.
22. Dzien A, Dzien-Bischinger C, Hoppichler F, Lechleitner M. The metabolic syndrome as a link between smoking and cardiovascular disease. Diabetes Obes Metab. 2004;6:127-32.
23. Villegas R, Creagh D, Hinchion R, O'Halloran D, Perry U. Prevalence and lifestyle determinants of the metabolic syndrome. Ir Med J. 2004;97:300-3.
24. Zhu S, St-Onge MP, Heshka S, Heymsfield SB. Lifestyle behaviors associated with lower risk of having the metabolic syndrome. Metabolism. 2004;53:1503-11.
25. Lee WY, Jung CH, Park JS, Rhee EJ, Kim SW. Effects of smoking, alcohol, exercise, education, and family history on the metabolic syndrome as defined by the ATP III. Diabetes Res Clin Pract. 2005;67:70-7.
26. Tonstad S, Svendsen M. Premature coronary heart disease, cigarette smoking, and the metabolic syndrome. Am J Cardiol. 2005;96:1681-5.
27. Liu J, Young TK, Zinman B, Harris SB, Connelly PW, Hanley AJ. Lifestyle variables, non-traditional cardiovascular risk factors, and the metabolic syndrome in an Aboriginal Canadian population. Obesity (Silver Spring). 2006;14:500-8.